Journal article

Evolution of eligibility criteria for diffuse large B-cell lymphoma randomised controlled trials over 30 years

Zoe Loh, Ross Salvaris, Geoffrey Chong, Leonid Churilov, Kate Manos, Allison Barraclough, Eliza A Hawkes

BRITISH JOURNAL OF HAEMATOLOGY | WILEY | Published : 2021

Abstract

Eligibility criteria for randomised control trials (RCT) in diffuse large B-cell lymphoma (DLBCL) may be becoming increasingly strict. In this analysis, 42 first-line phase III RCTs enrolling DLBCL patients since 1990 were identified from PubMed and clinicaltrials.gov. Changes in 31 individual eligibility criteria were assessed using three pre-defined eras [(1) 1993-2005; (2) 2006-2013; and (3) 2014-2020]. The presence of 15/31 criteria increased significantly over time, and the total number of criteria per study also increased over time [median Era 1: 14·5, interquartile range (IQR) 12·6-16·4; Era 2: 21, 18·8-23·3; Era 3: 23, 21-25; P < 0·001]. When each trial's eligibility criteria were ap..

View full abstract